Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways
- PMID: 33740220
- DOI: 10.1007/s10787-021-00800-3
Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways
Abstract
Cell signaling is considered a part of a network for communication that regulates basic cellular activities. The ability of cells to communicate correctly to the surrounding environment has an important role in development, tissue repair, and immunity as well as normal tissue homeostasis. Dysregulated activation and crosstalk between many intracellular signaling pathways are implicated in the pathogenesis of rheumatoid arthritis (RA), such as the Janus Kinase/signal transducers and activators of transcription (JAK/STAT), Toll-like receptor/nuclear factor kappa B (TLR/NF-κB), phosphatidylinositide-3Kinase/protein kinase B/mammalian target of rapamycin (PI-3K/AKT/mTOR), the stress activated protein kinase/mitogen-activated protein kinase (SAPK/MAPK), and spleen tyrosine kinase (SYK) pathways. Other interrelated pathways that can be targeted to halt the inflammatory status in the disease are purinergic 2X7 receptor (P2X7R)/nucleotide binding oligomerization domain-like receptor family pyrin domain containing 3 or inflammasome (NLRP-3)/NF-κB and Notch pathways. In this review, we will show the orchestrated modulation in the pathogenesis of RA via the crossregulation between dysregulated signaling pathways which can mediate a sustained loop of activation for these signaling pathways as well as aggrevate the inflammatory condition. Also, this review will highlight many targets that can be useful in the development of more effective therapeutic options.
Keywords: JAK/STAT; P2X7R/NLRP-3; PI-3K/AKT/mTOR; SAPK/MAPK; SYK; TLR/NF-κB.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.Life Sci. 2020 Nov 1;260:118261. doi: 10.1016/j.lfs.2020.118261. Epub 2020 Aug 12. Life Sci. 2020. PMID: 32795539
-
Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis.Clin Immunol. 2021 Sep;230:108793. doi: 10.1016/j.clim.2021.108793. Epub 2021 Jul 6. Clin Immunol. 2021. PMID: 34242749 Review.
-
Intracellular Signaling Pathways in Rheumatoid Arthritis.J Clin Cell Immunol. 2013 Aug 19;4:160. doi: 10.4172/2155-9899.1000160. J Clin Cell Immunol. 2013. PMID: 24619558 Free PMC article.
-
Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages.Am J Physiol Cell Physiol. 2004 Apr;286(4):C923-30. doi: 10.1152/ajpcell.00417.2003. Epub 2003 Dec 18. Am J Physiol Cell Physiol. 2004. PMID: 14684387
-
Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future?Biochem Pharmacol. 2022 Mar;197:114929. doi: 10.1016/j.bcp.2022.114929. Epub 2022 Jan 19. Biochem Pharmacol. 2022. PMID: 35065024 Review.
Cited by
-
Therapeutic effect of three-dimensional hanging drop cultured human umbilical cord mesenchymal stem cells on osteoarthritis in rabbits.Stem Cell Res Ther. 2024 Sep 18;15(1):311. doi: 10.1186/s13287-024-03905-y. Stem Cell Res Ther. 2024. PMID: 39294780 Free PMC article.
-
The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies.Front Immunol. 2023 Nov 8;14:1265818. doi: 10.3389/fimmu.2023.1265818. eCollection 2023. Front Immunol. 2023. PMID: 38022653 Free PMC article. Review.
-
Role of chemokine-like factor 1 as an inflammatory marker in diseases.Front Immunol. 2023 Feb 14;14:1085154. doi: 10.3389/fimmu.2023.1085154. eCollection 2023. Front Immunol. 2023. PMID: 36865551 Free PMC article. Review.
-
Selenium Mitigates Caerulein and LPS-induced Severe Acute Pancreatitis by Inhibiting MAPK, NF-κB, and STAT3 Signaling via the Nrf2/HO-1 Pathway.Biol Trace Elem Res. 2025 Sep;203(9):4728-4750. doi: 10.1007/s12011-025-04531-2. Epub 2025 Feb 5. Biol Trace Elem Res. 2025. PMID: 39907886
-
Targeting the ferroptosis pathway for rheumatoid arthritis: molecular mechanisms and prospects for inhibitor development.Front Immunol. 2025 Jun 10;16:1610121. doi: 10.3389/fimmu.2025.1610121. eCollection 2025. Front Immunol. 2025. PMID: 40557156 Free PMC article. Review.
References
-
- Aksoy E, Taboubi S, Torres D, Delbauve S, Hachani A, Whitehead MA et al (2012) The p110delta isoform of the kinase PI-3K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat Immunol 13:1045–1054. https://doi.org/10.1038/ni.2426 - DOI - PubMed - PMC
-
- Al-Rasheed NM, Al-Rasheed NM, Hasan IH, Al-Amin MA, Al-Ajmi HN, Mahmoud AM (2016) Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats. Drug Des Dev Ther 10:2095–2107. https://doi.org/10.2147/DDDT.S109287 - DOI
-
- Ambili R, Janam P (2017) A critique on nuclear factor-kappa B and signal transducer and activator of transcription 3: the key transcription factors in periodontal pathogenesis. J Indian Soc Periodontol 21:350–356. https://doi.org/10.4103/jisp.jisp_301_16 - DOI - PubMed - PMC
-
- Bose S, Banerjee S, Mondal A, Chakraborty U, Pumarol J, Croley C (2020) Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy. Cells 9:1451. https://doi.org/10.3390/cells9061451 - DOI - PMC
-
- Branimir A, Miroslav M (2014) Pathogenesis of rheumatoid arthritis. Reumatizam 61:19–23
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous